Publications

Adoptive cell therapy paper (coming soon) - Ligtenberg MA, Kiessling R (2015)

Cancer vaccine paper (coming soon) - Ligtenberg MA, Kiessling R (2015)

Tumor-immunology paper (coming soon) - Ligtenberg MA, Kiessling R (2015)

NF-κB activation during intradermal DNA vaccination is essential for eliciting tumor protective antigen-specific CTL responses. Hum Vaccin Immunother. 2013 - Ligtenberg MA, Rojas-Colonelli N, Kiessling R, Lladser A. (2013)

Harnessing DNA-induced immune responses for improving cancer vaccines. - Herrada AA, Rojas-Colonelli N, González-Figueroa P, Roco J, Oyarce C, Ligtenberg MA, Lladser A (2012)

DAI (DLM-1/ZBP1) as a genetic adjuvant for DNA vaccines that promotes effective antitumor CTL immunity. Mol. Therapy. 2011 - Lladser A, Mougiakakos D, Tufvesson H, Ligtenberg MA, Quest AF, Kiessling R, Ljungberg K (2011)

Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling. - Fros JJ, Liu WJ, Prow NA, Geertsema C, Ligtenberg M, Vanlandingham DL, Schnettler E, Vlak JM, Suhrbier A, Khromykh AA, Pijlman GP. (2010)